Cite
Harrington PE, Croghan MD, Fotsch C, et al. Optimization of a Potent, Orally Active S1P1 Agonist Containing a Quinolinone Core. ACS Med Chem Lett. 2011;3(1):74-8doi: 10.1021/ml200252b.
Harrington, P. E., Croghan, M. D., Fotsch, C., Frohn, M., Lanman, B. A., Pennington, L. D., Pickrell, A. J., Reed, A. B., Sham, K. K., Tasker, A., Arnett, H. A., Fiorino, M., Lee, M. R., McElvain, M., Morrison, H. G., Xu, H., Xu, Y., Zhang, X., Wong, M., & Cee, V. J. (2012). Optimization of a Potent, Orally Active S1P1 Agonist Containing a Quinolinone Core. ACS medicinal chemistry letters, 3(1), 74-8. https://doi.org/10.1021/ml200252b
Harrington, Paul E, et al. "Optimization of a Potent, Orally Active S1P1 Agonist Containing a Quinolinone Core." ACS medicinal chemistry letters vol. 3,1 (2012): 74-8. doi: https://doi.org/10.1021/ml200252b
Harrington PE, Croghan MD, Fotsch C, Frohn M, Lanman BA, Pennington LD, Pickrell AJ, Reed AB, Sham KK, Tasker A, Arnett HA, Fiorino M, Lee MR, McElvain M, Morrison HG, Xu H, Xu Y, Zhang X, Wong M, Cee VJ. Optimization of a Potent, Orally Active S1P1 Agonist Containing a Quinolinone Core. ACS Med Chem Lett. 2011 Nov 23;3(1):74-8. doi: 10.1021/ml200252b. eCollection 2012 Jan 12. PMID: 24900374; PMCID: PMC4025730.
Copy
Download .nbib